Lv1
30 积分 2024-05-27 加入
CKAP4 is a potential therapeutic target to overcome resistance to EGFR-TKIs in lung adenocarcinoma
4小时前
待确认
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial
3个月前
已完结
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study
3个月前
已完结
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial
3个月前
已完结
IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain
3个月前
已完结
Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study
3个月前
已完结
Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors
4个月前
已完结
RBM10 mutation as a potential negative prognostic/predictive biomarker to therapy in non-small-cell lung cancer
4个月前
已完结
Immune-related adrenal insufficiency: A single center retrospective analysis
5个月前
已完结
EGFR/MDM2 signaling promotes NF-κB activation via PPARγ degradation
5个月前
已完结
皖公网安备34019202002308
